Who we are
Bringing together decades of experience across thrombosis, vascular biology, ischemic disease and drug development
Leadership
Julia C. Owens, PhD
Chief Executive Officer
Bio
Richard Shea, MBA
President and Chief Operating Officer
Bio
Shahid Nimjee, MD, PhD
Co-founder and Chief Medical Officer
Bio
Rob Hughes, MBA
Chief Financial Officer
Bio
Stacy Nelson
Vice President, Global Drug Development
Bio
Board of Directors
Steven Gillis, PhD
Chairman of the Board
ARCH Venture Partners
Julia C. Owens, PhD
Chief Executive Officer
Shahid Nimjee, MD, PhD
Co-founder and Chief Medical Officer
Ari Nowacek, MD, PhD
ARCH Venture Partners
Thomas Needham, MBA
Broadview Ventures
Longview Ventures
Aiden Aceves, PhD
Insight Partners
Hannah Chang, MD, PhD
Platanus
David Adair, MD, MBA
Solas BioVentures
Scientific and Clinical Advisors
Bruce Sullenger, PhD
Co-founder
Professor of Surgery, Duke University Medical Center
Michael Hill, MD
Director of Stroke, University of Calgary;
Principal Investigator, ESCAPE NETWORK
Tudor Jovin, MD
Chairman of Neurology, Cooper Healthcare;
Principal Investigator, DAWN, REVASCAT
Ashutosh Jadhav, MD, PhD
Interventional Neurologist, Barrow Neurological Institute; Editor-in-Chief, Stroke Vascular and Interventional Neurology Journal
Bruce Campbell, MD, PhD
Head of Stroke & Neurology University of Melbourne; Co-PI of EXTEND-IA and EXTEND-IA TNK
Joseph P. Broderick, MD
Chair of Neurology, University of Cincinnati;
Co-PI, NIH StrokeNet
Pooja Khatri, MD, M.Sc.
Chief of Neurology, Yale School of Medicine;
Co-PI, NIH StrokeNet
Richard Becker, MD
Director and Physician-in-Chief, Heart, Lung and Vascular Institute; University of Cincinnati; Founding Editor-in-Chief, Journal of Thrombosis and Thrombolysis
Robert Harrington, MD
Professor of Medicine; Dean, Weill Cornell; Past President, AHA
Investment Partners
